Acta Scientific Pharmaceutical Sciences (ISSN: 2581-883X)

Review Article Volume 4 Issue 6

Novel COVID-19 Treatment with Novel Therapy

Javeria Fazal*

Department of Clinical Pharmacy, University of Calabria, Italy

*Corresponding Author: Javeria Fazal, Department of Clinical Pharmacy, University of Calabria, Italy.

Received: March 30, 2020; Published: May 11, 2020

×

The main purpose of this research is to laid down a new concept so to save lives of corona infected patients. As coronavirus is spreading widely in all over the world and many deaths have been reported due to this life threatening disease. So in this study, a new strategy has been introduced for the very old vitamin D in order to put forward that how vitamin D can be used as a primary precursor for the treatment of novel coronavirus as vitamin D is very important in boosting immune system.

×

References

×

Citation

Citation: Javeria Fazal. “Novel COVID-19 Treatment with Novel Therapy”.Acta Scientific Pharmaceutical Sciences 4.6 (2020): 13.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In




News and Events


  • Reviewer Certificate
    Certificate will be issues to the valued reviewer who worked on the Articles Peer Review process.
  • Publication Certificate
    Authors will be provided with the Publication Certificate after their successful publication
  • Last Date for submission
    Authors are requested to submit their manuscripts before September 30, 2025

Contact US